osimertinib
astrazeneca
['adaura', 'nsclc', 'sclc', 'osimertinib', 'aura ,(-laura)']
probably one of the most anticipated curves of #asco23 adaura trial -&gt;osimertinib after surgery significantly improves os in pts w resected egfr+ nsclc, impressive hr 0. 49, first targeted agent ever demonstrating survival improvement after surgery in lc. 
MD, PhD, Lead Thoracic Oncol. Unit @hospitalclinic, MedOnc, Prof. @unibarcelona, Researcher Transl Genom 🧬 Targeted Therapies @IDIBAPS, @EORTC @GECP_org, #LCSM